Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Organigram Holdings Inc (TSX:OGI)

1.320 -0.070 (-5.04%)
Streaming Delayed Price Updated: 4:00 PM EDT, Apr 4, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Organigram Holdings Inc

< Previous 1 2 3 4 5 Next >
Organigram Global to Host the OG Investor Session, its Inaugural Virtual Event for Investors, and Announcement of Name Change on TSX and NASDAQ
From Organigram Global Inc.
Via Business Wire
Organigram Enters U.S. Through Acquisition of Collective Project Beverages
From Organigram Holdings Inc.
Via Business Wire
Organigram Unveils Bold New Brand Identity Reflecting Market Leadership Position in Canada and Growing International Presence
From Organigram Holdings Inc.
Via Business Wire
Organigram Announces Results of Annual and Special Meeting, including Shareholder Approval of Name Change to Organigram Global Inc.
From Organigram Holdings Inc.
Via Business Wire
Organigram Closes Third Tranche of Previously Announced BAT Private Placement Investment
From Organigram Holdings Inc.
Via Business Wire
Organigram Reports First Quarter Fiscal 2025 Results
From Organigram Holdings Inc.
Via Business Wire
Organigram to Report First Quarter Fiscal 2025 Results on February 11, 2025
From Organigram Holdings Inc.
Via Business Wire
Organigram Reports Fourth Quarter and Fiscal 2024 Results
From Organigram Holdings Inc.
Via Business Wire
Organigram to Report Fourth Quarter and Fiscal 2024 Results on December 18, 2024
From Organigram Holdings Inc.
Via Business Wire
Organigram Wants To Become Canada's Largest Cannabis Company By Market Share Via $71M Acquisition Deal
Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI) has announced the acquisition of 100% of Motif Labs Ltd. for CA$90 million ($64 million), comprising of CA$50 million in cash and CA$40 million in... 
Via Benzinga
Topics Cannabis
Exposures Cannabis
Organigram Acquires Motif, Becoming Canada’s Largest Cannabis Company by Market Share
From Organigram Holdings Inc.
Via Business Wire
Organigram Launches FAST™ Nanoemulsion Gummies
From Organigram Holdings Inc.
Via Business Wire
Tobacco Giant Invests $30.8M In Cannabis Company: BAT Private Placement Second Of Three Tranches
Cannabis producer Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI) has closed the second of three tranches of the previously announced CA$124,559,674 ($92.3 million) follow-on strategic equity... 
Via Benzinga
Topics Cannabis
Exposures Cannabis
Organigram Closes Second Tranche of Previously Announced BAT Private Placement Investment
From Organigram Holdings Inc.
Via Business Wire
CEO Shake-Ups At Canopy, Curaleaf And Recent Top Exec And Board Changes In Cannabis And Psychedelics
In late July, nearly three months after New York Governor Kathy Hochul fired Chris Alexander, the former head of the state's Office of Cannabis Management (OCM), following an internal review, a series... 
Via Benzinga
Topics Cannabis
Exposures Cannabis
Organigram Reports 25% YoY Increase In Q3 Net Revenue, Significant Improvement In Adjusted EBITDA
Cannabis producer Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI) announced on Tuesday results for the third quarter ended June 30, 2024, revealing its net revenue increased 25% year-over-year to... 
Via Benzinga
Topics Cannabis
Exposures Cannabis
Organigram Reports Third Quarter Fiscal 2024 Results
From Organigram Holdings Inc.
Via Business Wire
Organigram Product Development Collaboration Completes Landmark Clinical Study on Nanoemulsion Technology
From Organigram Holdings Inc.
Via Business Wire
IM Cannabis, Organigram And Other Hot Cannabis Stocks Soon To Report Earnings, What Investors Need To Know Now
Medical cannabis company IM Cannabis Corp. (CSE: IMCC) (NASDAQ: IMCC), with operations in Israel and Germany, will report operational and financial results for the second quarter of 2024 ended June 30,... 
Via Benzinga
Topics Cannabis
Exposures Cannabis
Organigram to Report Third Quarter Fiscal 2024 Results on August 13, 2024
From Organigram Holdings Inc.
Via Business Wire
Organigram Announces Appointment of Craig Harris to Board of Directors
From Organigram Holdings Inc.
Via Business Wire
Organigram to Bolster Auto-Flower and Rare Cannabinoid Portfolio with Partial Third Tranche Investment of US $1M into Phylos
From Organigram Holdings Inc.
Via Business Wire
Organigram Supports Cannabis In Germany With $15M Initial Investment In This Berlin Marijuana Co.
Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI) announced on Tuesday a strategic investment aimed at expanding its presence within the burgeoning European cannabis market. The Toronto-based company... 
Via Benzinga
Topics Cannabis Intellectual Property
Exposures Cannabis Intellectual Property
Organigram Invests in Sanity Group, a Leading German Cannabis Company
From Organigram Holdings Inc.
Via Business Wire
Organigram And This Canadian Cannabis Brand Expand In Europe And Beyond
Germany's recent legislative push in the cannabis sector marks a significant turning point not only for the country but also for the European cannabis landscape. Europe has become more open-minded... 
Via Benzinga
Topics Cannabis
Exposures Cannabis
Organigram Signs Three Year Supply Agreement with Avida Medical in UK
From Organigram Holdings Inc.
Via Business Wire
Organigram Reports 262% Higher Quarterly Net Loss YoY, Makes Progress In International Markets
Via Benzinga
Organigram Reports Second Quarter Fiscal 2024 Results
From Organigram Holdings Inc.
Via Business Wire
Organigram to Report Second Quarter Fiscal 2024 Results on May 14, 2024
From Organigram Holdings Inc.
Via Business Wire
Organigram Recognized for Executive Gender Diversity by the Globe & Mail’s Women Lead Here Report for the Fourth Consecutive Year
From Organigram Holdings Inc.
Via Business Wire
< Previous 1 2 3 4 5 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.